Nexina Life Sciences Private Limited
About Nexina Life Sciences Private Limited
Data last updated:
Nexina Life Sciences Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2018PTC046490. Its GSTIN is 23AAGCN1880N1Z6 (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Vanita Parashar (Managing Director) and Nidhi Awasthi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.86 D K Honey Homes Kolar Road Nayapura, Bhopal, Madhya Pradesh, India – 462042.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.27 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹59.34 Lakh (net margin 5.3%) and EBITDA of ₹84.2 Lakh (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 54% over three years and 47% over five years.
The company has about 44 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No.86 D K Honey Homes Kolar Road Nayapura, Bhopal, Madhya Pradesh, India – 462042
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nexina Life Sciences Private Limited
The main business activity of Nexina Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nexina Life Sciences Private Limited FY 2025 filings available
Nexina Life Sciences Private Limited reported revenue of ₹11.27 Cr (up 43% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nexina Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 47% over five years, including 43% growth in the latest year. EBITDA rose 132% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nexina Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹84.2 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹59.34 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nexina Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nexina Life Sciences are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nexina Life Sciences Private Limited
Nexina Life Sciences Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rural Orchids India Private Limited | ₹11.27 Cr (FY 2024) | •••• | •••• | 1828.0% | •••• | Hyderabad, Telangana, India |
| Pi Minerals Private Limited | ₹11.27 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Kolkata, West Bengal, India |
| New Vision Impex Private Limited | ₹11.27 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Rajkot, Gujarat, India |
| Poonam Autowings Private Limited | ₹11.27 Cr (FY 2018) | •••• | •••• | 62.0% | •••• | Ahmedabad, Gujarat, India |
| Percept Brands Private Limited | ₹11.27 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Ahmedabad, Gujarat, India |
| Nexina Life Sciences Private Limited this company | ₹11.27 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Bhopal, Madhya Pradesh, India |
| Stratgen Healthcare Private Limited | ₹11.27 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Mumbai, Maharashtra, India |
| Santok Electricals Pvt Ltd | ₹11.27 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Mumbai, Maharashtra, India |
| Interlinks Overseas Private Limited | ₹11.27 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Delhi, India |
| RLT Fashions Private Limited | ₹11.27 Cr (FY 2020) | •••• | •••• | -3.0% | •••• | Kolkata, West Bengal, India |
| Hindon Forgeprivate Limited | ₹11.27 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Ghaziabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Nexina Life Sciences by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nexina Life Sciences Private Limited
Nexina Life Sciences Private Limited is audited by AMIT ASATI AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AMIT ASATI AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nexina Life Sciences Private Limited
Nexina Life Sciences has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nidhi Awasthi Also directs: Nexina Cdcare Private Limited | Director | 04 Jan 2019 | 7 Years 9 Months | Current |
| Yogendra Parashar | Director | 29 May 2021 | 5 Years 4 Months | Current |
| Vanita Parashar Also directs: Nexina Cdcare Private Limited | Managing Director | 07 Sep 2018 | 8 Years 1 Months | Current |
| Rajni Kulhar | Director | 04 Jan 2019 | 7 Years 9 Months | Current |
Ownership and Shareholding of Nexina Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nexina Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2024 | Axis Bank Limited | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Nexina Life Sciences Private Limited
Nexina Life Sciences Private Limited has a workforce of 44 employees as of Jan 31, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Nexina Life Sciences Private Limited
Nexina Life Sciences has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Nexina Cdcare Private Limited | U24230MP2021PTC058048 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Nexina Life Sciences Private Limited
Nexina Life Sciences Private Limited has 8 board changes on record since 2018: 4 appointments and 4 cessations. The latest: Shriram Garg ceased to be Director on 30 Jan 2024.
Credit Ratings, Litigation & Regulatory Alerts for Nexina Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nexina Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nexina Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nexina Life Sciences Private Limited
Nexina Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAGCN1880N1Z6 | Madhya Pradesh | Active | 16 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nexina Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nexina Life Sciences Private Limited
Nexina Life Sciences is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 September 2018 (8+ years old) and is registered under CIN U24239MP2018PTC046490.
Nexina Life Sciences reported revenue of ₹11.27 Cr for FY 2025 (up 43% YoY).
Nexina Life Sciences has 4 current directors:
- Vanita Parashar - Managing Director
- Nidhi Awasthi - Director
- Yogendra Parashar - Director
- Rajni Kulhar - Director
Nexina Life Sciences reported a net profit of ₹59.34 Lakh (net margin 5.3%) and EBITDA of ₹84.2 Lakh (EBITDA margin 7.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nexina Life Sciences is 54% over three years and 47% over five years. In the latest year (FY 2025) revenue rose 43%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nexina Life Sciences is 23AAGCN1880N1Z6, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Nexina Life Sciences is U24239MP2018PTC046490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nexina Life Sciences was incorporated on 07 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Nexina Life Sciences by revenue are Rural Orchids India Private Limited, Pi Minerals Private Limited, New Vision Impex Private Limited, Poonam Autowings Private Limited, Percept Brands Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Shriram Garg ceased to be Director on 30 Jan 2024. Yogendra Parashar ceased to be Additional Director on 25 Nov 2021. Yogendra Parashar was appointed as Director on 29 May 2021. Nexina Life Sciences has 8 board changes on record in total.
The registered office of Nexina Life Sciences is at H.No.86 D K Honey Homes Kolar Road Nayapura, Bhopal, Madhya Pradesh, India – 462042.